anxiety disorders - Page 1 | CARLAT PUBLISHING

Clinical Update

Non-Medication Strategies for Mild Anxiety

February 24, 2026

Sarah K. Rivelli, MD, FACP, FAPA. System Director, Consult Liaison, Department of Psychiatry and Behavioral Medicine, Carilion Clinic, Roanoke, VA.

Dr. Rivelli has no financial relationships with companies related to this material.

Practical, evidence-based lifestyle and behavioral techniques that ease mild anxiety without medication.

Research Update

Benzodiazepines, Quetiapine, and Pregabalin for Short-Term Anxiety

February 1, 2025

Dominic Le, MD

Dominic Le, MD. Dr. Le has no financial relationships with companies related to this material.

Does medication work for rapid reduction of anxiety? This review finds some surprising answers.

CLINICAL UPDATE

Social Anxiety Disorder: Diagnosis and Treatment

January 10, 2025

Daniel Carlat, MD

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.

Dr. Carlat provides an array of treatments for social anxiety disorder, from SSRIs to psychotherapy,

EXPERT Q&A

Philosophy of Psychiatry: Key Essentials for Therapists

April 17, 2024

Awais Aftab, MD.

Awais Aftab, MD. Psychiatrist in Cleveland, Ohio, and Clinical Assistant Professor of Psychiatry at Case Western Reserve University. He writes an online newsletter, Psychiatry at the Margins. Twitter: @awaisaftab

Dr. Aftab has no financial relationships with companies related to this material.

Although psychiatry and philosophy are largely theoretical disciplines, they have relevance in the everyday work of psychiatrists and psychotherapists.

CLINICAL UPDATE

CBT With Exposure and Response Prevention for OCD

December 5, 2023

Daniel Carlat, MD

Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.

Dr. Carlat has no financial relationships with companies related to this material.

Seven steps to implementing exposure and response prevention techniques.

Research Update

Mirtazapine Augmentation in OCD

November 9, 2023

Kate J. Travis, MD

Kate J. Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

In theory, mirtazapine may worsen OCD, or it may help. This first-of-its-kind trial puts it to the randomized test.

Expert Q&A

Treating OCD With Co-Occurring Conditions

November 1, 2023

Kate Dimond Fitzgerald, MD

Kate Dimond Fitzgerald, MD.

Child and adolescent psychiatrist; Ruane Professor of Child and Adolescent Psychiatry, Department of Psychiatry, Columbia University; New York State Psychiatric Institute, New York, NY.

Dr. Fitzgerald has no financial relationships with companies related to this material.

In this issue we offer the information you need to treat OCD when it is mixed with other diagnoses.

Expert Q&A

Deprescribing Benzos: A How-To Guide

October 31, 2023

Audrey Abelleira, PharmD, BCPP

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines are widely prescribed but carry significant risks. The best course of action for many patients is to have their benzodiazepine prescription discontinued, but physiologic dependence can make stopping benzodiazepines a big challenge. Dr. Abeillera teaches us how to identify those who might benefit from a taper and covers all the details on how to do it as safely and effectively as possible.